Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor
    1.
    发明授权
    Method of using cyclic peptides to inhibit binding to urokinase-type plasminogen activator receptor 失效
    使用环肽抑制与尿激酶型纤溶酶原激活物受体结合的方法

    公开(公告)号:US06514710B1

    公开(公告)日:2003-02-04

    申请号:US09285783

    申请日:1999-04-05

    IPC分类号: A61K3812

    摘要: Cyclic peptide compounds having 11 amino acids joined by a linking unit L, such that the linear dimension between the C&agr; carbon of the first amino acid and the C&agr; carbon of eleventh amino acid is between about 4 and 12 Ångstrom units; are useful for inhibiting the binding of uPA to the uPAR receptor. Methods for using the cyclic peptide compounds, and compositions containing them, for inhibiting the growth or metastasis of cancerous tumors are also disclosed.

    摘要翻译: 具有连接单元L连接的11个氨基酸的环肽化合物,使得第一氨基酸的Calpha碳与第十一氨基酸的Calpha碳之间的线性尺寸为约4至12埃单位; 可用于抑制uPA与uPAR受体的结合。 还公开了使用环肽化合物的方法和含有它们的组合物用于抑制癌性肿瘤的生长或转移。

    Cyclic peptides that bind to urokinase-type plasminogen activator
receptor
    4.
    发明授权
    Cyclic peptides that bind to urokinase-type plasminogen activator receptor 失效
    结合尿激酶型纤溶酶原激活物受体的环肽

    公开(公告)号:US5942492A

    公开(公告)日:1999-08-24

    申请号:US747915

    申请日:1996-11-12

    摘要: Cyclic peptide compounds having 11 amino acids joined by a linking unit L, such that the linear dimension between the C.sup..alpha. carbon of the first amino acid and the C.sup..alpha. carbon of eleventh amino acid is between about 4 and 12 .ANG.ngstrom units; are useful for inhibiting the binding of uPA to the uPAR receptor. Methods for using the cyclic peptide compounds, and compositions containing them, for inhibiting the growth or metastasis of cancerous tumors are also disclosed.

    摘要翻译: 具有由连接单元L连接的11个氨基酸的环状肽化合物,使得第一氨基酸的Cα碳与第十一氨基酸的Cα碳之间的直线尺寸为约4-12个氨基酸单元; 可用于抑制uPA与uPAR受体的结合。 还公开了使用环肽化合物的方法和含有它们的组合物用于抑制癌性肿瘤的生长或转移。